blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3103437

EP3103437 - SKIN LIGHTENING COMPOSITIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.11.2018
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  17.11.2017
FormerGrant of patent is intended
Status updated on  31.08.2017
FormerRequest for examination was made
Status updated on  03.02.2017
FormerThe application has been published
Status updated on  11.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
ELC Management LLC
767 Fifth Avenue
New York, NY 10153 / US
[2016/50]
Inventor(s)01 / NIKI, Yoko.
1192-374 Shinzaike Hiraoka-Cho
Kakogawa, Hyogo 675-0101 / JP
02 / YAROSH, Daniel B.
2915 Shore Drive
Merrick, NY New York 11566 / US
03 / MATSUI, Mary S.
483 Standish Road
Teaneck, NJ New Jersey 07666-2605 / US
04 / YOSHIDA, Masaki.
Room 504, Superior Kuwana, Ichiban-Kan
Fukujima 969-1
Kuwana, Mie 511-0002 / JP
05 / ICHIHASHI, Masamitsu.
19-8, 2-Chome Naruko Kita-ku
Kobe, Hyogo 651-1133 / JP
 [2016/50]
Representative(s)Hirsch & Associés
154 Boulevard Haussmann
75008 Paris / FR
[N/P]
Former [2016/50]Hirsch & Associés
137, rue de l'Université
75007 Paris / FR
Application number, filing date16175081.505.01.2011
[2016/50]
Priority number, dateUS20100292577P06.01.2010         Original published format: US 292577 P
[2016/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3103437
Date:14.12.2016
Language:EN
[2016/50]
Type: B1 Patent specification 
No.:EP3103437
Date:20.12.2017
Language:EN
[2017/51]
Search report(s)(Supplementary) European search report - dispatched on:EP19.10.2016
ClassificationIPC:A61K8/49, A61Q19/02, A61Q19/00
[2016/50]
CPC:
A61K8/49 (EP,KR,US); A61K8/4946 (US); A61P17/00 (EP);
A61P17/16 (EP); A61Q17/04 (US); A61Q19/00 (KR);
A61Q19/02 (EP,KR,US); A61K2800/782 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/10]
Former [2016/50]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:ZUSAMMENSETZUNGEN ZUR HAUTAUFHELLUNG[2016/50]
English:SKIN LIGHTENING COMPOSITIONS[2016/50]
French:COMPOSITIONS POUR ÉCLAIRCIR LA PEAU[2016/50]
Examination procedure17.06.2016Date on which the examining division has become responsible
24.01.2017Amendment by applicant (claims and/or description)
24.01.2017Examination requested  [2017/10]
01.09.2017Communication of intention to grant the patent
09.11.2017Fee for grant paid
09.11.2017Fee for publishing/printing paid
09.11.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP11732094.5  / EP2521531
Opposition(s)21.09.2018No opposition filed within time limit [2018/49]
Fees paidRenewal fee
17.06.2016Renewal fee patent year 03
17.06.2016Renewal fee patent year 04
17.06.2016Renewal fee patent year 05
17.06.2016Renewal fee patent year 06
24.01.2017Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.01.2011
AL20.12.2017
AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
MK20.12.2017
NL20.12.2017
PL20.12.2017
PT20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SI20.12.2017
SK20.12.2017
SM20.12.2017
TR20.12.2017
IE05.01.2018
LU05.01.2018
MT05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
[2020/34]
Former [2020/31]HU05.01.2011
AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
MK20.12.2017
NL20.12.2017
PL20.12.2017
PT20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SI20.12.2017
SK20.12.2017
SM20.12.2017
TR20.12.2017
IE05.01.2018
LU05.01.2018
MT05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2020/30]HU05.01.2011
AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
PT20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SI20.12.2017
SK20.12.2017
SM20.12.2017
TR20.12.2017
IE05.01.2018
LU05.01.2018
MT05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2020/28]AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
PT20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SI20.12.2017
SK20.12.2017
SM20.12.2017
TR20.12.2017
IE05.01.2018
LU05.01.2018
MT05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2020/16]AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SI20.12.2017
SK20.12.2017
SM20.12.2017
TR20.12.2017
IE05.01.2018
LU05.01.2018
MT05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2020/08]AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SI20.12.2017
SK20.12.2017
SM20.12.2017
IE05.01.2018
LU05.01.2018
MT05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2019/13]AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SI20.12.2017
SK20.12.2017
SM20.12.2017
IE05.01.2018
LU05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2019/09]AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SK20.12.2017
SM20.12.2017
IE05.01.2018
LU05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2018/51]AT20.12.2017
CY20.12.2017
CZ20.12.2017
DK20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SK20.12.2017
SM20.12.2017
LU05.01.2018
BE31.01.2018
CH31.01.2018
LI31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2018/50]AT20.12.2017
CY20.12.2017
CZ20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SK20.12.2017
SM20.12.2017
LU05.01.2018
BE31.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2018/47]AT20.12.2017
CY20.12.2017
CZ20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SK20.12.2017
SM20.12.2017
LU05.01.2018
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2018/44]AT20.12.2017
CY20.12.2017
CZ20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
MC20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SK20.12.2017
SM20.12.2017
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2018/40]AT20.12.2017
CY20.12.2017
CZ20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
NL20.12.2017
PL20.12.2017
RO20.12.2017
RS20.12.2017
SE20.12.2017
SK20.12.2017
SM20.12.2017
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2018/38]AT20.12.2017
CY20.12.2017
CZ20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
NL20.12.2017
PL20.12.2017
RS20.12.2017
SE20.12.2017
SK20.12.2017
SM20.12.2017
BG20.03.2018
NO20.03.2018
GR21.03.2018
IS20.04.2018
Former [2018/37]CY20.12.2017
CZ20.12.2017
EE20.12.2017
FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
NL20.12.2017
PL20.12.2017
RS20.12.2017
SE20.12.2017
SK20.12.2017
SM20.12.2017
BG20.03.2018
NO20.03.2018
GR21.03.2018
Former [2018/34]FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
NL20.12.2017
RS20.12.2017
SE20.12.2017
BG20.03.2018
NO20.03.2018
GR21.03.2018
Former [2018/24]FI20.12.2017
HR20.12.2017
LT20.12.2017
LV20.12.2017
RS20.12.2017
SE20.12.2017
BG20.03.2018
NO20.03.2018
GR21.03.2018
Former [2018/23]FI20.12.2017
HR20.12.2017
LT20.12.2017
RS20.12.2017
SE20.12.2017
NO20.03.2018
GR21.03.2018
Former [2018/22]FI20.12.2017
LT20.12.2017
NO20.03.2018
Documents cited:Search[Y]WO2004080430  (3M INNOVATIVE PROPERTIES CO [US]) [Y] 1-6 * claims 1-11 * * page 5, line 12 - page 7, line 7 * * page 9, line 8 - page 10, line 8 *;
 [Y]EP1657242  (BANYU PHARMA CO LTD [JP]) [Y] 1-6 * paragraph [0298]; claim 18 *;
 [A]EP0068378  (SCHERING CORP [US]) [A] 1-6 * the whole document *;
 [A]WO9815276  (THERASYS INC [US], et al) [A] 1-6 * claims 1-12 *
 [A]  - SCOTT C K ET AL, "Inhibition of H<+>K<+> ATPase by SCH 28080 and SCH 32651", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER SCIENCE, NL, vol. 112, no. 2, doi:10.1016/0014-2999(85)90508-4, ISSN 0014-2999, (19850607), pages 268 - 270, (19850607), XP025547300 [A] 1-6 * the whole document *

DOI:   http://dx.doi.org/10.1016/0014-2999(85)90508-4
by applicantUS4677152
 US4702844
 US3439088
 US3818105
 US5118496
 US5183589
 US4803067
 US5183588
 US4970252
 US5760116
 US5654362
 JPS6118708
 US5236986
 US5412004
 US5837793
 US5811487
 WO2004024798
 US5843193
 US3215724
 US3781417
 US5077211
 US5190762
 US5272079
 US5296231
    - OLBE, L.; CARLSSON E.; LINDBERG P., "A Proton-Pump Inhibitor Expedition: The Case Histories of Omeprazole and Esomeprazole", NATURE REVIEWS DRUG DISCOVERY, (2003), vol. 2, pages 132 - 9
    - BRILLIANT, M.; GARDNER, J., "Melanosomal pH, Pink Locus Protein and their Roles in Melanogenesis", J. OF INVEST. DERMATOL., (2001), vol. 117, no. 2
    - MOELLMANN, G.; SLOMINSKI, A.; KUKLINSKA, E.; LERNER A. B., "Regulation of Melanogensis in Melanocytes", PIGMENT CELL RES., (1988), vol. 1, pages 79 - 87
    - BHATNAGAR, V.; ANJAIAH, S. PURI; N, ARUDHRA; DARSHANAM, B. N.; RAMAIA, A., "pH of Melanosomes of B16 Murine Melanoma is Acidic: Its Physiological Importance in the Regulation of Melanin Biosynthesis", ARCH. BIOCHEM. BIOPHYS., (1993), vol. 307, doi:doi:10.1006/abbi.1993.1577, pages 183 - 192, XP024753524

DOI:   http://dx.doi.org/10.1006/abbi.1993.1577
    - RAMAIAH, A., "Lag Kinetics of Tyrosinase: Its Physiologic Implications", INDIAN J. BIOCHEM. AND BIOPHYS, (1996), vol. 33, pages 349 - 356
    - VAN DYKE, R.W., "Acidification of Lysosomes and Endosomes", SUB-CELLULAR BIOCHEM., (1996), vol. 27, pages 331 - 360
    - GRABE, M.; OSTER, G., "Regulation of Organelle Acidity", J. GENERAL PHYSIOL., (2001), vol. 117, pages 329 - 344
    - DEVI, C.C.; TRIPATHI R. K.; RAMAIA, A, "pH-dependent Interconvertible Allosteric Forms of Murine Melanoma Tyrosinase: Physiological Implications", EUR. J. BIOCHEM., (1987), vol. 166, pages 705 - 711
    - GUNATHILIAKE R.; SCHURER N.; SHOO B.; CELLI, A.; HACHEM J. P; CURMRINE D.; SIRIMANNA, G.; FEINGOLD K.; MAURO T.; ELIAS P., "pH-regulated Mechanism Accounts for Pigment-Type Differences in Epidermal Barrier Function", J. INVEST. DERMATOL,, (2009), vol. 129, pages 1719 - 1729
    - HEARING, V. J.; EKEL, T. M., "Mammalian Tyrosinase. A Comparison of Tyrosine Hydroxylation and Melanin Formation", J. BIOCHEM., (1976), vol. 157, pages 549 - 557
    - SAEKI, H.; OIKAWA, A., "Stimulation of Ionophores of Tyrosinase Activity of Mouse Melanoma Cells in Culture", J. INVESTIG. DERMATOL., (1985), vol. 85, pages 423 - 425
    - TOWNSEND, D.; GUILLERY, P.; KING. R. A., "Optimized Assay for Mammalian Tyrosinase (Polyphenol Phenyloxidase", ANAL. BIOCHEM., (1984), vol. 139, doi:doi:10.1016/0003-2697(84)90015-0, pages 345 - 352, XP024824306

DOI:   http://dx.doi.org/10.1016/0003-2697(84)90015-0
    - ANCANS, J, D.; TOBIN, J.; HOOGDUJIN, J. J.; SMIT, N. P.; WAKAMATSU, K.; THODY, A. J., "Melanosomal pH Controls Rate of Melanogenesis, Eumelanin/Phaeomelanin Ratio and Melanosome Maturation in Melanocytes and Melanoma Cells", EXPERIMENTAL CELL RESEARCH, (2001), vol. 268, doi:doi:10.1006/excr.2001.5251, pages 26 - 35, XP055095348

DOI:   http://dx.doi.org/10.1006/excr.2001.5251
    - SMITH ET AL., "The Relationship Between Na+/H+ Exchanger Expression and Tyrosinase Activity in Human Melanocytes", EXPTL. CELL RES., (2004), vol. 298, doi:doi:10.1016/j.yexcr.2004.04.033, pages 521 - 534, XP009145771

DOI:   http://dx.doi.org/10.1016/j.yexcr.2004.04.033
    - PURI, N.; GARDNER, J. M.; BRILLIANT, M.H., "Aberrant pH of Melanosomes in Pink-eyed Dilution (p) Mutant Melanocytes", SOC. INVEST. DERMATOL., (2000), vol. 115, doi:doi:10.1046/j.1523-1747.2000.00108.x, pages 607 - 613, XP002438616

DOI:   http://dx.doi.org/10.1046/j.1523-1747.2000.00108.x
    - ANCANS, J.; HOODUIJN, J.; THODY, A. J., "Melanosomal pH, Pink Locus Protein and their Roles in Melanogenesis", J. INVEST. DERMATOL., (2001), vol. 117, no. 1, pages 158 - 159
    - HALABAN, R.; PATTON, R. S.; CHENG, E.; SVEDINE, S.; TROMBETTA, E. S.; WAHL, M. L.; ARUJAN, S.; HEBERT, D. N., "Abnormal Acidification of Melanoma Cells Induces Tyrosinase Retention in the Early Secretory Pathways", J. BIOL. CHEM., (2002), vol. 277, no. 17, doi:doi:10.1074/jbc.M111497200, pages 14821 - 14828, XP002441622

DOI:   http://dx.doi.org/10.1074/jbc.M111497200
    - CHANG, H.; SACCOMANI G.; RABON, E.; SCHACKMANN R.; SACHS, G., "Proton Transport by Gastric Membrane Vesicles", BIOCHIM ET BIOPHYSICA ACTA, (1977), vol. 464, no. 2, doi:doi:10.1016/0005-2736(77)90006-2, pages 313 - 327, XP023351494

DOI:   http://dx.doi.org/10.1016/0005-2736(77)90006-2
    - SACHS G.; WALLMARK, B., "The Gastric H+K+ ATPase: The Site of Action of Omeprazole", SCAND. J. OF GASTROENTEROL, (1989), vol. 24, no. S166, pages 3 - 11
    - ROBINSON, M.; HOME, J., "Clinical Pharmacology of Proton Pump Inhibitors: What the Practicing Physician Needs to Know", DRUGS, (2003), vol. 63, pages 2739 - 2754
    - ROCHE, V. F., "The Chemically Elegant Proton Pump Inhibitors", AMER. J. PHAR. EDUC, (2006), vol. 70, no. 5
    - QAISI, A. M.; TUTUNJI, J. F.; TUTUNJI, L. F., "Acid Decomposition of Omeprazole in the Absence of Thiol: a Differential Pulse Polarographic Study at the Static Mercury Drop Electrode (SMDE", J. PHARM. SCI., (2006), vol. 95, no. 2, pages 384 - 391
    - BESANCON, M.; SHIN, J. M.; MERCIER, F.; MUNSON, K.; MILLER, M.; HERSEY, S.; SACHS, G., "Membrane Topology and Omeprazole Labelling of the Gastric H+, K(+) Adenosinetriphosphatase", BIOCHEM, (1993), vol. 32, no. 9, pages 2345 - 2355
    - BESANCON, M.; SIMON, A.; SACHS, G.; SHIN, J. M., "Sites of Reaction of the Gastric H, K-ATPase with Extracytoplasmic Thiol Reagents", J. OF BIOL. CHEM., (1997), vol. 272, doi:doi:10.1074/jbc.272.36.22438, pages 22438 - 446, XP003013211

DOI:   http://dx.doi.org/10.1074/jbc.272.36.22438
    - CHELI, Y.; LUCIANI, F.; KHALED, M.; BEURET, L.; BILLIE, K.; GOUNON, PI; ORTONNE, J. P; BERTOLOTTO, C.; BALLOTTI, R., "Alpha-MSH and cyclic-AMP elevating agents control melanosome pH through a PKA-independent mechanism", J. BIOL. CHEM., (2009), vol. 284, pages 18699 - 18706
    - WALLMARK B.; C. BRIVING; J. FRYKLUND; K. MUNSON; R. JACKSON; J. MENDLEIN; E. RABON; G. SACHS, "Inhibition of Gastric H+,K+-ATPase and Acid Secretion by SCH28080, a Substituted Pyridyl 1(1,2 a)imidazole", J. BIOL. CHEM., (1987), vol. 262, pages 2077 - 2084
    - BEIL; HATCHBARTH, I; SEWING, K. F. ET AL., "Mechanism of Gastric Antisecretory Effect of SCH 28080", BR. J. PHARMAC, (1986), vol. 88, pages 19 - 23
    - ASANO S.; S. MATSUDA; Y. TEGA; K. SHIMIZU; S. SAKAMOTO; N. TAKEGUCHI, "Mutational Analysis of Putative SCH28080 Binding Sites of the Gastric H+,K+- ATPase", J. BIOL. CHEM., (1997), vol. 272, pages 17668 - 17674
    - CTFA Cosmetic Ingredient Handbook, vol. 2, pages 1646 - 1660
    - FITZPATRICK, T.B., "Ultraviolet-induced Pigmentary Changes: benefits and hazards", CURR. PROBL. DERMATOL., (1986), vol. 15, pages 25 - 38
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.